The current HAE market cap is 4.25B. The company's latest EPS is USD 2.2723 and P/E is 36.82.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 305.3M | 304.42M | 311.33M | 318.18M | 336.25M |
Operating Income | 43.28M | 35.26M | 53.66M | 35.3M | 45.98M |
Net Income | 32.94M | 29.38M | 41.04M | 24.91M | 31.24M |
Year End March 31 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 967.58M | 988.48M | 903.28M | 1B | 1.17B |
Operating Income | 83.55M | 153.95M | 90.78M | 81.33M | 155.65M |
Net Income | 55.02M | 76.53M | 79.47M | 43.38M | 115.4M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.88B | 1.93B | 1.96B | 2.01B | 2.2B |
Total Liabilities | 1.1B | 1.12B | 1.1B | 1.12B | 1.26B |
Total Equity | 775.98M | 818M | 864.62M | 893.66M | 943.32M |
Year End March 31 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.27B | 1.27B | 1.82B | 1.86B | 1.93B |
Total Liabilities | 606.9M | 680M | 1.09B | 1.11B | 1.12B |
Total Equity | 667.87M | 587.11M | 731.67M | 749.42M | 818M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 193.45M | 273.06M | 19.09M | 118.21M | 117.67M |
Investing | -125.78M | -143.79M | -15.26M | -40.4M | -309.33M |
Financing | -98.76M | -100.36M | -598k | -7.77M | 101.66M |
Year End March 31 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 159.28M | 158.22M | 108.81M | 172.26M | 273.06M |
Investing | -116.15M | -57.18M | -425.44M | -86.35M | -143.79M |
Financing | -50.63M | -131.21M | 367.45M | -15.75M | -100.36M |
Market Cap | 4.25B |
Price to Earnings Ratio | 36.82 |
Price to Sales Ratio | 3.64 |
Price to Cash Ratio | 14.94 |
Price to Book Ratio | 5.19 |
Dividend Yield | - |
Shares Outstanding | 50.79M |
Average Volume (1 week) | 552.42k |
Average Volume (1 Month) | 435.63k |
52 Week Change | -2.12% |
52 Week High | 95.26 |
52 Week Low | 70.74 |
Spread (Intraday) | 8.39 (9.36%) |
Company Name | Haemonetics Corp |
Address |
155 federal street boston, massachusetts 02110 |
Website | https://www.haemonetics.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.